RYTM

Rhythm Pharmaceuticals, Inc.

HealthcareBiotechnologyUSUSDPeers →

$96.79

LiveJun 18, 2026

AI Brief

Market cap

$6.64B

52w range

60.80 – 122.20

P / E

—

EPS

—

Volume

1.46M

Revenue · FY

—

Overview Fundamentals Valuation Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Rhythm Pharmaceuticals, Inc.’s valuation

decile 5 · 0% factors bull

News pulse · 14d

5 storiesPositive +1.00All news →

06-08today

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Positive Interim Results from Phase 2 Setmelanotide Trial in Prader-Willi Syndrome Transcript2d
Why Is Rhythm Pharma Stock Jumping Today?4d
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome7d
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome7d

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$89.70

Change

-17.70%

Period high

$108.99

Period low

$77.25

Period start

$108.992026-02-02

Through 2026-06-15

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $139.57 (+44.20%)

Candlestick · 1Y

Open in chart workstation →

RYTM

89.70-17.70%

H 111.25L 74.50MA50 88.49MA200 —Avg vol 838K

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+1.00%	+10.43%	+10.98%	+7.18%	-13.69%	-9.58%	+56.14%	+391.57%	+363.11%	+222.63%	+222.63%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 18, 10:56 PM

Last trade

$98.72

Bid

$89.70

1 sh

Ask

$100.00

101 sh

Spread

$10.300

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Technology
+2.51%
Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Consumer Defensive
-0.30%
Energy
-0.45%
Industrials
-0.48%
Basic Materials
-0.66%
Financial Services
-0.67%
Real Estate
-0.99%
Healthcare
-1.51%

Top industries (issuer's industry highlighted)

Biotechnology
+0.28%
Oil & Gas Energy
+8.53%
Business Equipment & Supplies
+5.82%
Semiconductors
+5.24%
Electronic Gaming & Multimedia
+5.23%
Advertising Agencies
-5.20%
Medical - Equipment & Services
+5.08%
Grocery Stores
-4.35%
Financial - Mortgages
+4.08%
Broadcasting
+4.00%
Computer Hardware
-3.67%
Internet Content & Information
+3.58%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent analyst activity

6 latest

Jun 17, 2026GradeBuy → BuyBest Smidcap Ideas: TD Cowen Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)Cowen & Co.
Jun 16, 2026PT$151.00Rhythm Pharmaceuticals (RYTM) PT Raised to $151 at CanaccordCanaccord Genuity
Jun 15, 2026PT$133.00Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM) Post Release of Setmelanotide DataStifel Nicolaus
Jun 15, 2026GradeOverweight → OverweightRhythm Pharmaceuticals price target raised to $155 from $144 at Wells FargoWells Fargo
Jun 15, 2026PT$155.00Rhythm Pharmaceuticals price target raised to $155 from $144 at Wells FargoWells Fargo
Jun 03, 2026GradeMarket Outperform → Market OutperformRhythm Pharmaceuticals (RYTM) Reiterated at Market Outperform by CitizensCitigroup

Peers

No peer list available for RYTM.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin